Prostate Cancer and the Celtic Curse
The latest of my "30 articles in one month" series to raise money for prostate cancer research looks at a surprising overlap between my cancer and my wife's debilitating genetic condition: Celtic Curse.
![]() |
| Celtic Curse is the genetic form of haemochromatosis which causes iron overload |
What the heck is Celtic Curse?
In Ireland, an astounding one in five people carry a genetic mutation linked to iron overload, a condition where the body absorbs too much iron which can lead to health problems. About one in 80 have the double gene mutation required to develop iron overload (homozygous C282Y). This mutation goes back thousands of years. The numbers are lower, but still serious in Scotland and the places to which a lot of people from that part of the world have emigrated over the centuries.
The official name for this inherited condition is Hereditary Hemochromatosis (HH) and when you look it up on standard public health portals like NHS England, the summary usually notes that it can lead to fatigue, joint pain, and if left untreated, risk of diabetes and liver disease or liver cancer. The treatment for HH is described as "just giving blood" because that reduces the amount of iron in your body.
However, while liver cancer is the headline threat from HH, standard public health pages often understate the broader picture. Mounting large-scale genetic research shows that untreated iron overload doesn’t just harm the liver; it creates a fertile environment for cancer cells to thrive throughout the body, including the prostate.
I happen to know about Celtic Curse the same way I came to learn about prostate cancer: it impacted someone close to me. About a decade before my brother found out he had prostate cancer, my wife learned she had iron overload and genetic hemochromatosis (homozygous C282Y). She was already experiencing damage to joints and organs.
Naturally, I set about learning as much as I could about HH, ten sharing what I found on a dedicated Facebook page and blog (CelticCurse.org). I documented that journey last year in an article titled: Hemochromatosis, haemochromatosis, and iron overload redux.
The iron-prostate cancer connection
Iron is vital for carrying oxygen in our blood, but in excess, it is volatile.When your body lacks the genetic "brakes" to regulate iron absorption, most commonly due to two copies of the C282Y gene mutation, excess iron spills out of normal storage proteins into your organs and bloodstream. This extra, unmanaged iron triggers two cellular disasters:
- Cellular Damage (Free Radicals): Free-floating iron reacts with oxygen to generate destructive molecules called free radicals. These molecules strip electrons from surrounding tissue, damaging cellular DNA and introducing mutations that can trigger cancer.
- Feeding Tumor Growth: Cancer cells have an aggressive appetite for iron. They use it to fuel rapid cell division and building new DNA. In short, excess tissue iron acts like high-octane fuel for early-stage tumor growth.
The most striking impact of untreated HH is on the liver. Men with two copies of the primary HH gene mutation (C282Y homozygotes) are 10 times more likely to develop primary liver cancer compared to the general population.
Roughly 1 in 14 men with untreated HH will develop liver cancer by age 75 (compared to less than 1 in 150 men without the mutation). While liver cancer often follows cirrhosis (severe liver scarring), large studies show that 10% to 15% of HH patients who develop liver cancer have no cirrhosis at all. The excess iron directly damages DNA long before total organ failure occurs.
Historically, the relationship between iron and liver cancer has long been known and extensively studied, but less attention has been paid to links between hemochromatosis and extrahepatic or non-liver cancers, such as prostate cancer. More recently however, large population studies, such as the 450,000-person UK Biobank study, have uncovered significant links.
Men carrying two copies of the C282Y mutation show a 32% increased risk of developing prostate cancer. That means about 1 in 7 men with high-risk HH genes are projected to develop prostate cancer by age 75, compared to about 1 in 10 in the broader population. Because iron accumulates in glandular tissues, the prostate appears particularly vulnerable to chronic oxidative stress.
What does this mean for your health?
I think it means that men over 40 should know their ferritin levels as well at their PSA level. I will describe ferritin levels in a moment. Both prostate cancer and iron overload develop slowly and this means early detection improves your chance of heading off serious long-term consequences. Fortunately, treatment for early stage iron overload really is a simple as giving blood (although more frequently that voluntary donations and monitored by a doctor).
Two blood tests are used to determine if you are experiencing iron overload due to hereditary hemochromatosis:
- Serum ferritin: measures the amount of iron stored in the body. Values above 200–300 µg/L in males are typically flagged as high, depending on the lab.
- Serum transferrin saturation (Tsat): measures how much iron in the blood is bound to the protein transferrin. A value of 45% or higher is generally considered elevated, and this is usually the first-line screening test. Ideally it's measured after an overnight fast, as eating can affect the result.
You can order these tests privately, but your GP or primary care doctor should be able to order them if you say you are feeling fatigued, losing interest in sex, and have joint pain. Also, mention any indication of Irish or Scottish connections in your genetic background, however distant, as well as any family history of liver disease, diabetes, or heart problems.
If ferritin blood tests suggest iron overload, doctors will typically order genetic testing to look for mutations in the HFE gene, specifically C282Y and H63D. If they find you have two copies of the C282Y mutation that confirms hereditary hemochromatosis (with a few exceptions).
If you do have HH you should, in my opinion, pay closer attention to PSA levels, even if your ferritin numbers are normal. I would also check that my lifestyle is not iron-heavy (think less red meat, no iron and vitamin C supplements, no raw or undercooked shellfish, iron-fortified foods, and no excessive alcohol.
There are companies offering HFE tests for around $100/£80. This will tell you if you have the C282Y or H63D mutations. Your HFE status is also included in genetic platforms like 23andMe or Ancestry DNA (although it's harder to figure out via Ancestry DNA). You can sometimes get discounted HFE-only genetic tests via non-profits and charities like Haemochromatosis UK and Iron Disorders Institute in the US.
References:
Atkins, J. L., Pilling, L. C., Masoli, J. A. H., & Melzer, D. (2020). Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy. JAMA, 324(20), 2048–2057.
Atkins, J. L., Pilling, L. C., Torti, S. V., Torti, F. M., Kuchel, G. A., & Melzer, D. (2022). Hereditary Hemochromatosis Variant Associations with Incident Nonliver Malignancies: 11-Year Follow-up in UK Biobank. Cancer Epidemiology, Biomarkers & Prevention, 31(9), 1780–1787.









